Laurus Labs signs and symptoms agreement with MPP to manufacture Molnupiravir

Laurus Labs signs and symptoms agreement with MPP to manufacture Molnupiravir

by admin- Friday, January 21st, 2022 04:00:24 PM

Laurus Labs signed an settlement with MPP (Medicine Patient Pool) for the manufacturing of the oral COVID-19 antiviral medicine Molnupiravir.

News Updates